scorecardresearch
Add as a preferred source on Google
Thursday, January 29, 2026
TopicDilip Shanghvi

Topic: Dilip Shanghvi

Sun Pharmaceuticals undergoes SEBI-ordered forensic audit

The latest probe points to challenges for India’s biggest drugmaker after whistle-blower complaints on corporate governance lapses triggered a stock slide last year.

Dilip Shanghvi of Sun Pharmaceutical’s to keep stake in Suzlon Energy despite falling value

In 2015, billionaire Dilip Shanghvi bought 23% stake for Rs 18 billion, but Suzlon still hasn’t exited India’s debt-restructuring program, missing deadlines since 2017.

On Camera

How Djokovic & his luck outplayed opponents in major tournaments—walkovers to retirements

By the 2024 US Open, ESPN noted that Djokovic had advanced via opponent retirements or walkovers 16 times at Majors, the most of any male player in the Open Era.

Congress calls India’s GDP numbers ‘suspect’, alleges manipulation by Modi govt

In AICC report ‘Real State of the Economy 2026’, Congress flags ‘central contradiction’ in economy, calls for data review pointing to jobs, FDI, manufacturing slump & inequality.

Indian Army ties up with US drone company that made its name in the Ukraine conflict

Shield AI will provide V-BAT vertical takeoff & landing drones along with licences for software, which will be integrated into aircraft and made available to select Indian partners.

Non-alignment is coming back in a new avatar: Trump-peedit alliance

No nation other than China can negotiate one-on-one with Trump on an equal footing. That’s why the middle powers who so far formed the core of multilateral bodies now feel orphaned.